Answers are grounded in this paper and cite their sources.
Reveals the prognostic value of Ki67 and PSA immunostaining in metastatic hormone-sensitive prostate cancer, suggesting improved risk stratification.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: